Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BOOSTCAMP CBD for anxiety symptoms before therapy
2024-514783-78-00Phase 2Completed
- Sponsor
- University Medical Center Utrecht
- Start
- Oct 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of cannabidiol in post-traumatic stress disorder (PTSD) and anxiety disorder, sponsored by University Medical Center Utrecht. Primary endpoint: Beck Anxiety Index change between week 1 and week 2. Started Oct 2024; status: completed.
02
Drugs
cannabidiol
03
Conditions
post-traumatic stress disorder (PTSD)anxiety disorder
Beyond the preview
Go deeper on 2024-514783-78-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2024-514783-78-00.